中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2015年
6期
1429-1431
,共3页
周敏%牛朝诗%鲍得俊%程传东%丁宛海
週敏%牛朝詩%鮑得俊%程傳東%丁宛海
주민%우조시%포득준%정전동%정완해
胶质瘤%手术%睾酮%化学免疫发光法%临床意义
膠質瘤%手術%睪酮%化學免疫髮光法%臨床意義
효질류%수술%고동%화학면역발광법%림상의의
Glioma%Operation%Testosterone%Chemical immunofluorescence technique%Clinical significance
目的 观察脑胶质瘤患者手术前后睾酮水平及其变化,并探讨其临床意义.方法 采用微粒子化学发光免疫分析方法检测实验组(脑胶质瘤病例组)及对照组(颅内良性肿瘤、功能性疾病等病例组)术前、术后静脉血睾酮水平,两组均进行开颅手术.结果 脑胶质瘤患者血清睾酮水平[男性:(15.25±4.68) nmol/L、女性:(1.17 ±0.59) nmol/L]明显高于颅内良性肿瘤或功能性神经疾病患者[男性:(10.81±2.51)nmol/L、女性:(0.42±0.34) nmol/L],脑胶质瘤手术后3~4d睾酮水平下降程度[男性:(8.62±4.66) nmol/L、女性:(0.55 ±0.13) nmol/L]较功能性神经疾病或颅内良性肿瘤患者明显[男性:(3.79±2.66) nmol/L、女性:(-0.45 ±0.12)nmol/L],且差异有统计学意义(P<0.05).脑胶质瘤组术后6~9d血清睾酮水平变化与术后3~4 d差异无统计学意义(P>0.05).睾酮水平及其变化与胶质瘤密切相关,但与脑胶质瘤病理级别无相关性.脑胶质瘤患者血清睾酮水平均较颅内其他肿瘤和功能性神经疾病的血清睾酮浓度高,差异有统计学意义.手术切除肿瘤后,胶质瘤组睾酮水平较术前明显减低;而在对照组,手术后睾酮水平稍降低,很快又恢复至术前水平.结论 脑胶质瘤患者血清中存在睾酮代谢失衡与紊乱.
目的 觀察腦膠質瘤患者手術前後睪酮水平及其變化,併探討其臨床意義.方法 採用微粒子化學髮光免疫分析方法檢測實驗組(腦膠質瘤病例組)及對照組(顱內良性腫瘤、功能性疾病等病例組)術前、術後靜脈血睪酮水平,兩組均進行開顱手術.結果 腦膠質瘤患者血清睪酮水平[男性:(15.25±4.68) nmol/L、女性:(1.17 ±0.59) nmol/L]明顯高于顱內良性腫瘤或功能性神經疾病患者[男性:(10.81±2.51)nmol/L、女性:(0.42±0.34) nmol/L],腦膠質瘤手術後3~4d睪酮水平下降程度[男性:(8.62±4.66) nmol/L、女性:(0.55 ±0.13) nmol/L]較功能性神經疾病或顱內良性腫瘤患者明顯[男性:(3.79±2.66) nmol/L、女性:(-0.45 ±0.12)nmol/L],且差異有統計學意義(P<0.05).腦膠質瘤組術後6~9d血清睪酮水平變化與術後3~4 d差異無統計學意義(P>0.05).睪酮水平及其變化與膠質瘤密切相關,但與腦膠質瘤病理級彆無相關性.腦膠質瘤患者血清睪酮水平均較顱內其他腫瘤和功能性神經疾病的血清睪酮濃度高,差異有統計學意義.手術切除腫瘤後,膠質瘤組睪酮水平較術前明顯減低;而在對照組,手術後睪酮水平稍降低,很快又恢複至術前水平.結論 腦膠質瘤患者血清中存在睪酮代謝失衡與紊亂.
목적 관찰뇌효질류환자수술전후고동수평급기변화,병탐토기림상의의.방법 채용미입자화학발광면역분석방법검측실험조(뇌효질류병례조)급대조조(로내량성종류、공능성질병등병례조)술전、술후정맥혈고동수평,량조균진행개로수술.결과 뇌효질류환자혈청고동수평[남성:(15.25±4.68) nmol/L、녀성:(1.17 ±0.59) nmol/L]명현고우로내량성종류혹공능성신경질병환자[남성:(10.81±2.51)nmol/L、녀성:(0.42±0.34) nmol/L],뇌효질류수술후3~4d고동수평하강정도[남성:(8.62±4.66) nmol/L、녀성:(0.55 ±0.13) nmol/L]교공능성신경질병혹로내량성종류환자명현[남성:(3.79±2.66) nmol/L、녀성:(-0.45 ±0.12)nmol/L],차차이유통계학의의(P<0.05).뇌효질류조술후6~9d혈청고동수평변화여술후3~4 d차이무통계학의의(P>0.05).고동수평급기변화여효질류밀절상관,단여뇌효질류병리급별무상관성.뇌효질류환자혈청고동수평균교로내기타종류화공능성신경질병적혈청고동농도고,차이유통계학의의.수술절제종류후,효질류조고동수평교술전명현감저;이재대조조,수술후고동수평초강저,흔쾌우회복지술전수평.결론 뇌효질류환자혈청중존재고동대사실형여문란.
Objective To investigate the change of serum testosterone in patients with glioma.Methods The serum level of testosterone in glioma group and control group before and after operation were measured by chemical immunofluorescence technique.All the patients in these two groups were performed craniotomy operation.Results The serum level of testosterone in glioma patients [male (15.25 ± 4.68) nmol/L,female (1.17 ±0.59) nmol/L] was significantly higher than that in patients with benign tumors or functional diseases [male (10.81 ± 2.51) nmol/L,female (0.42 ± 0.34) nmol/L].Three or four days later after operation,the reduction of serum testosterone was more obvious in glioma patients [male (8.62 ±4.66) nmol/L,female (0.55 ±0.13) nmol/L] than that in control group [male (3.79 ± 2.66) nmol/L,female (-0.45 ±0.12) nmol/L] (P <0.05).The change of testosterone in 6-9 days after operation compared to the change in 3-4 days after operation showed no statistical significance in glioma group (P > 0.05).However,there was no significant difference of the level of testosterone before and after operation in patients with different WHO grade of glioma.Conclusion It is significant that the serum testosterone level is higher in patients with glioma than that in patients with benign tumor or functional diseases group.After removing the tumor,the serum testosterone level decrease more than than in the control group.However,in the control group,the level of testoterone recover soom after sugery.So we can conclude that there are disorders and imbalances of testosterone metabolism in patients with glioma.